Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon.
about
Differential expression of human nicotinic acetylcholine receptor alpha subunit variants in muscle and non-muscle tissuesExtra-domain B in Oncofetal Fibronectin Structurally Promotes Fibrillar Head-to-tail Dimerization of Extracellular Matrix ProteinRegulated tissue-specific expression of antagonistic pre-mRNA splicing factors.Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespanCo-assembly of plasma and cellular fibronectins into fibrils in human fibroblast culturesFibronectins, their fibrillogenesis, and in vivo functions.Isolation of anti-angiogenesis antibodies from a large combinatorial repertoire by colony filter screening.Neurite outgrowth on a fibronectin isoform expressed during peripheral nerve regeneration is mediated by the interaction of paxillin with alpha4beta1 integrinsTumor-infiltrating B lymphocytes as an efficient source of highly specific immunoglobulins recognizing tumor cells.Multiple forms of chicken alpha 3(VI) collagen chain generated by alternative splicing in type A repeated domainsAlternative splicing of the angiogenesis associated extra-domain B of fibronectin regulates the accessibility of the B-C loop of the type III repeat 8.A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondinA case of cervical cancer expressed three mRNA variant of Hyaluronan-mediated motility receptor.Selective targeted delivery of the TNF-alpha receptor p75 and uteroglobin to the vasculature of inflamed tissues: a preliminary report.Alternative splicing of endothelial cell fibronectin mRNA in the IIICS region. Functional significance.Splice variants of zinc finger protein 695 mRNA associated to ovarian cancer.Regulation of fibronectin expression in rat regenerating liver.A chemically modified antibody mediates complete eradication of tumours by selective disruption of tumour blood vessels.A phase 1 study of AS1409, a novel antibody-cytokine fusion protein, in patients with malignant melanoma or renal cell carcinoma.Use of the uteroglobin platform for the expression of a bivalent antibody against oncofetal fibronectin in Escherichia coli.Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition processDifferentiation between high- and low-grade astrocytoma using a human recombinant antibody to the extra domain-B of fibronectin.Epigenetic reversion of breast carcinoma phenotype is accompanied by changes in DNA sequestration as measured by AluI restriction enzyme.Loss of EDB+ fibronectin isoform is associated with differentiation of alveolar epithelial cells in human fetal lung.Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritisDefective anti-listerial responses in deciduoma of pseudopregnant miceTissue stiffness regulates serine/arginine-rich protein-mediated splicing of the extra domain B-fibronectin isoform in tumorsC6: A Monoclonal Antibody Specific for a Fibronectin Epitope Situated at the Interface between the Oncofoetal Extra-Domain B and the Repeat III8.Differential ASF/SF2 activity in extracts from normal WI38 and transformed WI38VA13 cells.A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursorsReappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat.Retroviral expression of alternatively spliced forms of rat fibronectinModulation of cell-adhesive activity of fibronectin by the alternatively spliced EDA segment.Biodistribution studies with tumor-targeting bispecific antibodies reveal selective accumulation at the tumor siteTissue-specific splicing pattern of fibronectin messenger RNA precursor during development and aging in ratUrinary oncofetal ED-A fibronectin correlates with poor prognosis in patients with bladder cancerCharacterisation and radioimmunotherapy of L19-SIP, an anti-angiogenic antibody against the extra domain B of fibronectin, in colorectal tumour models.Cytotoxic targeting of F9 teratocarcinoma tumours with anti-ED-B fibronectin scFv antibody modified liposomesA novel mechanism of Ha-ras oncogene action: regulation of fibronectin mRNA levels by a nuclear posttranscriptional event.Retroviral insertions downstream of the heterogeneous nuclear ribonucleoprotein A1 gene in erythroleukemia cells: evidence that A1 is not essential for cell growth.
P2860
Q24596898-8078E696-EBD6-4745-A639-C86F6C18C5CDQ27678169-990BE088-A4DC-4CF7-A128-BE1BD205D247Q28582631-5406872B-DD27-476C-A8DE-A71792C52EB4Q28593378-6DEC5B65-33DB-4378-B78F-23ACC6325EDFQ28756471-27DDDC4E-5611-454B-AE9B-C2BAEBBDF13AQ30421926-08051DE3-C7B9-4F71-B58D-0E89FB921888Q30655755-A53E5FD7-9305-4EE5-BF46-3E7448E9BADBQ33289525-B972DE6D-DAD5-4E3D-A463-D47BC862671AQ33303060-7A4F09C6-7120-46B8-98B4-0A0B84D7128EQ33506451-21D643BF-2615-49C0-A094-7238D7186A58Q33531787-78D7ECB0-4BF1-43A6-B1AD-4902ABECC85FQ33763790-9CEAC324-61C8-48AC-B31E-9AF7B432BF94Q33802642-41D99646-3D8F-4CA8-8484-43442603EF25Q34072266-E3ABEEEC-E968-45A5-9258-DF1C78EAC6ECQ34273918-B5C4024B-13ED-426D-9592-0D3E80000890Q34368827-A51DC852-90EB-48FF-AF6E-832539D7621CQ34735161-62529F17-74B0-4A09-A613-061137CF1E4DQ34746019-9EE9ABB0-C30E-433B-9DB5-7159DFB025FCQ34764827-3D615ACE-1197-48F1-BFD0-772BEF3B6228Q35075470-4D7E7E1B-0BE3-45FF-8E90-05E64AA06A32Q35470512-F6FDEB60-2C70-4A18-A506-5B0B8E7EABEFQ35747752-0D5B4F2B-D6DF-4D52-A95C-5974DABA108BQ35757244-A04F4658-A7F9-4B19-9FFD-C6F006686591Q35763827-546B9B1A-0715-489C-A93A-0B54767579FFQ35769069-FD151298-2183-469D-BF65-6200CF478F4DQ35819137-F9CBF3B3-C898-4189-BA91-F3F2302E3FB4Q35845913-07464B27-2B27-49EE-AB82-E202181F05DBQ35920869-BB359BE8-3D72-4096-87DC-7CCF393E6AFFQ35930823-C57DC0AE-4F64-422A-99D5-D13EC12A8ED7Q36219964-5740FA5C-22B3-4D89-9337-714BAC16A5BEQ36221328-7031D27D-1F15-475E-991D-4CD0D95E886DQ36222724-E96E3FAF-998C-4219-B3CB-CBBE571ADD0AQ36273978-370081A1-B24C-47C9-95CD-66E37C428269Q36411863-B54D6F15-E738-43A6-8572-09A2284DE050Q36529824-173ED6A6-0BBD-43F7-8683-059333DD1F60Q36547455-C6C2E68F-BF7D-4393-8481-58A8A6B6B017Q36609642-10546595-7033-4E35-9EA1-06D0BA2FD610Q36624175-6451544B-2DB3-4109-90FE-F8D66B310FB9Q36652198-86D49572-75B6-40D2-B660-5549D2ADD6B8Q36703019-65361D7C-3BC9-4334-A18F-A754BEF22CF4
P2860
Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Transformed human cells produc ...... a previously unobserved exon.
@en
type
label
Transformed human cells produc ...... a previously unobserved exon.
@en
prefLabel
Transformed human cells produc ...... a previously unobserved exon.
@en
P2093
P2860
P1433
P1476
Transformed human cells produc ...... a previously unobserved exon.
@en
P2093
Baralle FE
Carnemolla B
Paolella G
Petersen TE
Sebastio G
P2860
P304
P407
P577
1987-08-01T00:00:00Z